Advertisement
Surgery
Advanced searchSave search
Retraction Notice| Volume 173, ISSUE 4, P1109, April 2023

Retraction notice to <Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase (RRM2): a novel therapeutic strategy in pancreatic cancer [Surgery 136 (2004) 261-269]

Published:February 10, 2023DOI:https://doi.org/10.1016/j.surg.2023.01.008
Retraction notice to <Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase (RRM2): a novel therapeutic strategy in pancreatic cancer [Surgery 136 (2004) 261-269]
Previous ArticleRetraction notice to Glucose transporter-1 gene expression is associated with pancreatic cancer invasiveness and MMP-2 activity [Surgery -September 2004, Pages 548-556]
Next ArticleCover 1(with editorial board)
      This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal).
      This article has been retracted at the request of the Editors-in-Chief, because an investigation by Harvard Medical School and the Brigham and Women’s Hospital has concluded that Figure 1A is invalid and no underlying research data are available to resolve the discrepancies or validate the reported results.

      Article info

      Publication history

      Published online: February 10, 2023

      Identification

      DOI: https://doi.org/10.1016/j.surg.2023.01.008

      Copyright

      © 2023 Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      Linked Article

      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX